🧠 Top 10 Neurotechnology Startups in Europe Transforming Diagnosis & Treatment (2024–2026)

The Neurotechnology Revolution in Europe

Neurological and mental health disorders represent one of the largest and fastest-growing healthcare challenges in Europe. According to leading public health estimates, nearly 165 million Europeans live with brain-related disorders, and 1 in 3 people will be affected by a neurological or psychiatric condition at some point in their lifetime.

From Alzheimer’s disease, Parkinson’s disease, epilepsy, stroke, and multiple sclerosis to depression, anxiety, and cognitive decline, brain disorders account for a significant proportion of disability-adjusted life years (DALYs) and healthcare expenditure across Europe.

Against this backdrop, neurotechnology—the convergence of neuroscience, engineering, AI, and digital health—is emerging as a transformative force. European startups are leading the way with breakthroughs in:

• 🧠 Brain–computer interfaces (BCIs)

• 📊 AI-powered neuroimaging and diagnostics

• ⌚ Wearable EEG and digital biomarkers

• 💡 Non-invasive neuromodulation

• 📱 Digital therapeutics and remote monitoring

These innovations are not only improving diagnostic accuracy and treatment precision, but also democratizing access to neurological care, empowering patients, and reshaping clinical workflows.

Below, we highlight 10 European neurotechnology startups that are redefining how neurological and mental health conditions are diagnosed, monitored, and treated between 2024 and 2026.

---

🔹 1. INBRAIN Neuroelectronics (Barcelona, Spain)

Focus: Brain–Computer Interfaces (BCIs) & Neuromodulation
Leadership: Carolina Aguilar

INBRAIN Neuroelectronics is pioneering the use of graphene-based neural interfaces to decode and modulate brain activity with unprecedented precision. Their implantable neurotechnology aims to treat conditions such as Parkinson’s disease, epilepsy, and other movement disorders.

By combining advanced materials science with neuroscience, INBRAIN’s platforms enable high-resolution brain signal recording and stimulation, opening new possibilities for personalized neuromodulation therapies and closed-loop brain–machine systems.

Why it matters:

• Ultra-precise neural decoding

• Next-generation implants with improved safety and longevity

• Potential paradigm shift in neurosurgical treatment

---

🔹 2. BIOSerenity (Paris, France)

Focus: Wearable Neurological Diagnostics
Leadership: Emmanuel Mougeotte

BIOSerenity develops wearable medical-grade sensors integrated with AI analytics for real-world monitoring of neurological disorders, particularly epilepsy and sleep-related conditions.

Their solutions enable continuous data capture outside hospital settings, allowing clinicians to detect abnormalities earlier and make better-informed treatment decisions.

Why it matters:

• Moves diagnostics from hospitals to daily life

• Improves detection of episodic neurological events

• Reduces diagnostic delays and misdiagnosis

---

🔹 3. Raidium (Paris, France)

Focus: AI in Radiology
Leadership: Paul Hérent, MD, MSc

Raidium leverages artificial intelligence to enhance CT and MRI image analysis, enabling faster, more accurate identification of neurological abnormalities such as stroke, tumors, and vascular conditions.

Their technology supports radiologists by automating time-sensitive detection tasks, improving diagnostic confidence and efficiency in acute and chronic neurological care.

Why it matters:

• Faster diagnosis in critical neurological emergencies

• Reduces clinician workload

• Enhances precision medicine in neuroimaging

---

🔹 4. Quibim (Valencia, Spain)

Focus: Quantitative Imaging Biomarkers
Leadership: Ángel Alberich-Bayarri

Quibim transforms medical images into quantitative, AI-powered imaging biomarkers that support diagnosis, prognosis, and personalized treatment planning in neurology.

Their platforms allow clinicians to move beyond visual interpretation, enabling objective measurement of disease progression in conditions such as neurodegeneration and brain tumors.

Why it matters:

• Data-driven, reproducible imaging insights

• Enables personalized treatment pathways

• Supports clinical trials and real-world evidence

---

🔹 5. NeuroX (London, United Kingdom)

Focus: Wearable EEG & Continuous Brain Monitoring
Leadership: Anoop Antony

NeuroX is developing wearable EEG-based neural interfaces designed for continuous brain monitoring. These systems aim to detect early signs of cognitive decline, neurological dysfunction, and brain health deterioration.

By enabling long-term, non-invasive monitoring, NeuroX supports proactive and preventive neurological care.

Why it matters:

• Early detection of neurodegenerative conditions

• Continuous, real-world brain data

• Supports preventive neurology models

---

🔹 6. Nuuron (Berlin, Germany)

Focus: At-Home Neurostimulation
Leadership: Fabian Queisner

Nuuron focuses on non-invasive, home-based neurostimulation technologies aimed at supporting memory and cognitive function in neurodegenerative diseases.

Their patient-centric approach reduces reliance on clinical visits while empowering individuals to engage actively in their cognitive health management.

Why it matters:

• At-home therapeutic innovation

• Improves adherence and accessibility

• Complements pharmacological treatments

---

🔹 7. Moovd (Netherlands)

Focus: Digital Therapeutics & Neuro-Mental Wellness
Leadership: Susanne E. Baars, MSc, MA

Moovd develops digital therapeutic solutions that enhance access to mental and neurological wellness support. Their tools integrate behavioral science, digital health, and user-centered design.

By lowering barriers to care, Moovd contributes to more inclusive and scalable neuro-mental health solutions.

Why it matters:

• Expands access to care

• Bridges neurology and mental health

• Scalable digital-first interventions

---

🔹 8. HelloBetter (Hamburg, Germany)

Focus: Clinically Validated Digital Mental Health Programs
Leadership: Hannes Klöpper

HelloBetter offers evidence-based, clinically validated online programs addressing mental health conditions that frequently co-occur with neurological disorders, such as depression, anxiety, and stress-related symptoms.

Their solutions are increasingly integrated into healthcare systems and reimbursed models.

Why it matters:

• Strong clinical validation

• Scalable population-level impact

• Addresses mind–brain comorbidity

---

🔹 9. Syntropic Medical (Austria)

Focus: Neurostimulative Light Therapy
Leadership: Mark Caffrey

Syntropic Medical is exploring neurostimulative light-based therapies for treatment-resistant psychiatric and neurological symptoms.

Their approach represents a novel, non-invasive modality with potential applications across mood disorders, cognitive dysfunction, and neurological rehabilitation.

Why it matters:

• Non-invasive alternative therapies

• Addresses treatment-resistant conditions

• Expands the neuromodulation toolbox

---

🔹 10. iLoF (Oxford, UK / Portugal)

Focus: AI + Photonics Biomarker Discovery
Leadership: Luís Valente

iLoF combines AI, photonics, and non-invasive blood analysis to accelerate biomarker discovery for Alzheimer’s disease and related neurodegenerative disorders.

Their technology aims to enable earlier diagnosis, improved patient stratification, and faster drug development.

Why it matters:

• Early detection of Alzheimer’s disease

• Non-invasive and scalable diagnostics

• Accelerates precision neurology and research

---

🌍 The Bigger Picture: Why These Startups Matter

Together, these innovators are reshaping neurological care by driving:

✅ Earlier and more accurate diagnosis
✅ Personalized and data-driven treatment pathways
✅ Remote monitoring and patient empowerment
✅ Integration of AI, wearables, and advanced analytics
✅ Scalable solutions for overburdened healthcare systems

As neurological and mental health disorders continue to rise, these startups are not merely innovating—they are redefining the future of brain health in Europe.

---

📅 Join the Conversation at a Global Platform

4th European Congress of Neurology and Neuropsychiatry

📍 Paris, France
🗓 February 23–24, 2026
🏨 Venue: Hyatt Place Paris CDG Airport

🎯 Theme: Brain and Mental Health: Navigating the Future of Neurology and Psychiatry

📩 For Registration & Enquiries: info@neurologyconf.com
🌐 More Insights: www.neurologyconf.com

#Neurotech #HealthInnovation #Neurology #AIinHealthcare #BrainHealth #DigitalHealth #MentalHealth #Startups #Europe #Neuropsychiatry